|
Name |
4,7,7-Trimethylbicyclo[4.1.0]hept-2-ene
|
Molecular Formula | C10H16 | |
IUPAC Name* |
4,7,7-trimethylbicyclo[4.1.0]hept-2-ene
|
|
SMILES |
CC1CC2C(C2(C)C)C=C1
|
|
InChI |
InChI=1S/C10H16/c1-7-4-5-8-9(6-7)10(8,2)3/h4-5,7-9H,6H2,1-3H3
|
|
InChIKey |
LGNSZMLHOYDATP-UHFFFAOYSA-N
|
|
Synonyms |
4-Carene; 4,7,7-Trimethylbicyclo[4.1.0]hept-2-ene; 29050-33-7; (+)-4-Carene; UNII-PGD00V83F3; (-)-4,7,7-Trimethylbicyclo(4.1.0)hept-2-ene; PGD00V83F3; Bicyclo(4.1.0)hept-2-ene, 4,7,7-trimethyl-, (-)-; CHEBI:89934; DTXSID80871119; DB-009809; DB-071478; DB-071479; FT-0692431; FT-0740960; 4,7,7-Trimethylbicyclo[4.1.0]hept-2-ene #; EN300-188036; Q27162117
|
|
CAS | 29050-33-7 | |
PubChem CID | 530422 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 136.23 | ALogp: | 3.3 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 0.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 10 | QED Weighted: | 0.446 |
Caco-2 Permeability: | -4.362 | MDCK Permeability: | 0.00002530 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.005 |
30% Bioavailability (F30%): | 0.049 |
Blood-Brain-Barrier Penetration (BBB): | 0.899 | Plasma Protein Binding (PPB): | 90.96% |
Volume Distribution (VD): | 2.11 | Fu: | 12.31% |
CYP1A2-inhibitor: | 0.524 | CYP1A2-substrate: | 0.706 |
CYP2C19-inhibitor: | 0.21 | CYP2C19-substrate: | 0.894 |
CYP2C9-inhibitor: | 0.365 | CYP2C9-substrate: | 0.684 |
CYP2D6-inhibitor: | 0.03 | CYP2D6-substrate: | 0.769 |
CYP3A4-inhibitor: | 0.191 | CYP3A4-substrate: | 0.365 |
Clearance (CL): | 14.458 | Half-life (T1/2): | 0.146 |
hERG Blockers: | 0.004 | Human Hepatotoxicity (H-HT): | 0.011 |
Drug-inuced Liver Injury (DILI): | 0.039 | AMES Toxicity: | 0.005 |
Rat Oral Acute Toxicity: | 0.068 | Maximum Recommended Daily Dose: | 0.04 |
Skin Sensitization: | 0.045 | Carcinogencity: | 0.039 |
Eye Corrosion: | 0.926 | Eye Irritation: | 0.958 |
Respiratory Toxicity: | 0.279 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001145 | 0.286 | D0V8HA | 0.204 | ||||
ENC000574 | 0.286 | D04CSZ | 0.191 | ||||
ENC000153 | 0.286 | D05VQI | 0.188 | ||||
ENC002652 | 0.283 | D0K7LU | 0.188 | ||||
ENC001166 | 0.280 | D0F1UL | 0.182 | ||||
ENC001898 | 0.273 | D0P0HT | 0.179 | ||||
ENC002228 | 0.267 | D0D2TN | 0.176 | ||||
ENC000790 | 0.267 | D08PIQ | 0.176 | ||||
ENC001834 | 0.259 | D0CZ1Q | 0.176 | ||||
ENC001321 | 0.259 | D0I5DS | 0.176 |